medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2015, Number 4

<< Back Next >>

Rev Mex Patol Clin Med Lab 2015; 62 (4)

Systemic lupus erythematosus secondary to infection with Epstein-Barr virus

Romero-Cabello R, Romero FR, Romero FR

Language: English
References: 10
Page: 253-255
PDF size: 194.04 Kb.


ABSTRACT

Systemic lupus erythematosus (SLE) is a chronic, systemic, idiopathic and autoimmune disease. Infection with the Epstein-Barr virus (EBV) is a risk factor associated with the development of SLE. Almost all pediatric patients with SLE have serological evidence of EBV infection. Patients with SLE have increased EBV viral load in serum and saliva. These patients have 15-30 times the amount of viral DNA in peripheral blood. In this case the association between SLE and EBV infection is shown as well as the possibility of viral involvement as a trigger for the development of an aggressive form of LES.


REFERENCES

  1. McClain MT, Poole BD, Bruner BF. An altered immune response to Epstein-Barr Nuclear Antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum. 2006; 54 (1): 360-368.

  2. Poolea BD, Templeton AK, Guthridge JM et al. Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. Autoimmun Rev. 2009; 8 (4): 337-342.

  3. Gross AJ, Hochberg D, Rand WM et al. EBV ans systemic lupus erythematosus: a new perspective. J Immunol. 2005; 174: 6599-6607.

  4. Draborg AH, Duus K, Housen G. Epstein-Barr Virus ans systemic lupus erythematosus. Clin Dev Immunol. 2012; 2012: 370516.

  5. Kang I, Quan T, Nolasco H et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol. 2004; 172 (2): 1287-1294.

  6. Lünemann JD, Kamradt T, Martin R et al. Epstein-Barr Virus: Environmental trigger of multiple sclerosis? J Virol. 2007; 81 (13): 6777-6784.

  7. Moon UY, Park SJ, Oh ST et al. Patients with systemic lupus erytematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther. 2004; 6: R295-R302.

  8. Quan TE, Roman RM, Rudenga BJ et al. Epstein-Barr Virus promotes interferon-α production by plasmacytoid dendritic cells. Arthritis Rheum. 2010; 62 (6): 1693-1701.

  9. Harley JB, James JA. Everyone comes from somewhere: Systemic lupus erythematosus (SLE) and Epstein-Barr Virus, induction of host interferon (INF) and humoral anti-EBNA 1 immunity. Arthritis Rheum. 2010; 62 (6): 1571-1575.

  10. Cooper GS, Gilbert KM, Greindinger EL et al. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. Environ Health Perspect. 2008; 116 (6): 695-702.




2020     |     www.medigraphic.com